ABC Trials Joint Analysis: TC vs TaxAC in High-Risk, HER2-Negative Early Breast Cancer

Slideset - Treatment with TaxAC superior to TC in pooled analysis of women with resected high-risk HER2-negative early breast cancer.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research